PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Secukinumab in plaque psoriasis: Manufacturer dossier provided no hint of an added benefit

Partly lack of suitable data, partly no relevant differences between the treatment groups

2015-09-08
(Press-News.org) Secukinumab (trade name: Cosentyx) has been approved since January 2015 for adults with moderate to severe plaque psoriasis. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier, however: In patients who are candidates for systemic treatment, an indirect comparison provided no suitable data because the minimum study duration had not been reached. In adults in whom other systemic treatments have been unsuccessful or unsuitable, the results from a direct comparison showed no statistically significant differences in comparison with the comparator group.

Study duration too short

The drug manufacturer presented an indirect comparison with methotrexate as comparator therapy for adults with plaque psoriasis who are candidates for systemic treatment and/or phototherapy. Placebo was used as common comparator.

A chronic condition such as moderate to severe plaque psoriasis requires longterm treatment. Studies with a minimum duration of 24 weeks are therefore needed to assess an added benefit. However, the five studies on secukinumab treatment presented by the company only lasted 12 weeks each; and the only study on methotrexate treatment lasted only 16 weeks. Hence the manufacturer dossier provided no suitable data and therefore no hint of an added benefit for this patient group.

No relevant group differences

For adults with plaque psoriasis for whom systemic treatment is not an option or in whom it has been unsuccessful, the manufacturer compared secukinumab with ustekinumab. It presented data of a total of 313 patients after a treatment duration of 24 weeks from an ongoing study for this comparison. However, there were no statistically significant differences between the treatment groups, neither regarding remission nor regarding symptoms and complaints or severe side effects and treatment discontinuations due to adverse events. Regarding the effect of the treatment on quality of life, the manufacturer presented data after a study duration of 16 weeks. These were unsuitable for the assessment because the study duration was too short. Hence no added benefit resulted from the manufacturer dossier for this patient group either.

INFORMATION:

G-BA decides on the extent of added benefit

This dossier assessment is part of the early benefit assessment according to the Act on the Reform of the Market for Medicinal Products (AMNOG) supervised by the Federal Joint Committee (G-BA). After publication of the dossier assessment, the G-BA conducts a commenting procedure and makes a final decision on the extent of the added benefit.

An overview of the results of IQWiG's benefit assessment is given by a German-language executive summary. In addition, the Website gesundheitsinformation.de, published by IQWiG, provides easily understandable German-language Information.

More English-language information will be available soon (Sections 2.1 to 2.6 of the dossier assessment as well as subsequently published health information on informedhealthonline.org). If you would like to be informed when these documents are available, please send an e-mail to » info@iqwig.de.



ELSE PRESS RELEASES FROM THIS DATE:

Indications of the origin of the Spin Seebeck effect discovered

2015-09-08
This news release is available in German. The recovery of waste heat in all kinds of processes poses one of the main challenges of our time to making established processes more energy-efficient and thus more environmentally friendly. The Spin Seebeck effect (SSE) is a novel, only rudimentarily understood effect, which allows for the conversion of a heat flux into electrical energy, even in electrically non-conducting materials. A team of physicists at Johannes Gutenberg University Mainz (JGU), the University of Konstanz, TU Kaiserslautern, and the Massachusetts Institute ...

WSU researchers create super-stretchable metallic conductors for flexible electronics

2015-09-08
PULLMAN, Wash.--Washington State University researchers have discovered how to stretch metal films used in flexible electronics to twice their size without breaking. The discovery could lead to dramatic improvements and addresses one of the biggest challenges in flexible electronics, an industry still in its infancy with applications such as bendable batteries, robotic skins, wearable monitoring devices and sensors, and connected fabrics. The work was led by Rahul Panat and Indranath Dutta, researchers in Voiland College's School of Mechanical and Materials Engineering, ...

Survey reinforces further understanding of dietary deficiencies and optimum nutrition needed

2015-09-08
September 8, 2015, New York, New York- Data from a three-country survey seeking to understand beliefs of adults on the role of diet for optimal health, as well as consumption of key micronutrients including Omega-3 and Vitamin D, will be published in the November/December issue of Nutrition Today. The survey of 3,000 American, British and German adults found that 72 percent reported having a "healthy" or "optimal" diet and more than half (52 percent) believed they consume all the key nutrients needed for optimal nutrition through food sources alone. However, the prevalence ...

Reviving extinct Mediterranean forests, urban land-sparing, ocean noise pollution

2015-09-08
Extinct Mediterranean forests of biblical times could return and thrive in warmer, drier future. The Mediterranean has cradled humanity and our cities, farms, domesticated animals, and logging habits for many thousands of years. During the last 5 to 8 millennia, as people developed farming and settled in cities, the landscape has gradually changed from a thick canopy of trees to open grass and shrubs. The ghosts of Sicily's extinct evergreen forests of holm oak (Quercus ilex) and olive trees (Olea europaea) remain in the record of pollen left in the lakebed sediments. ...

Brain damage during stroke may point to source of addiction

2015-09-08
A pair of studies suggests that a region of the brain - called the insular cortex - may hold the key to treating addiction. Scientists have come to this conclusion after finding that smokers who suffered a stroke in the insular cortex were far more likely to quit smoking and experience fewer and less severe withdrawal symptoms than those with strokes in other parts of the brain. "These findings indicate that the insular cortex may play a central role in addiction," said Amir Abdolahi Ph.D., M.P.H., lead author of the studies. "When this part of the brain is damaged during ...

Biomarker helps predict survival time in gastric cancer patients

2015-09-08
Philadelphia, PA, September 8, 2015 - Gastric cancer poses a significant health problem in developing countries and is typically associated with late-stage diagnosis and high mortality. A new study in The American Journal of Pathology points to a pivotal role played by the biomarker microRNA (miR)-506 in gastric cancer. Patients whose primary gastric cancer lesions express high levels of miR-506 have significantly longer survival times compared to patients with low miR-506 expression. In addition, miR-506 suppresses tumor growth, blood vessel formation, and metastasis. "Epithelial-to-mesenchymal ...

Policy recommendations for use of telemedicine in primary care

2015-09-08
1. ACP recommends policies for practicing telemedicine in primary care Free: http://www.annals.org/article.aspx?doi=10.7326/M15-0498 Editorial: http://www.annals.org/article.aspx?doi=10.7326/M15-1416 URLs go live when embargo lifts In a new position paper, the American College of Physicians (ACP) says that telemedicine can improve access to care, but policies are needed to balance the benefits and risks for both patients and physicians. The authors note that conscious scrutiny is especially important as policymakers and stakeholders shape the landscape for ...

Ancient genomes link early farmers to Basques

Ancient genomes link early farmers to Basques
2015-09-07
An international team led by researchers at Uppsala University reports a surprising discovery from the genomes of eight Iberian Stone-Age farmer remains. The analyses revealed that early Iberian farmers are the closest ancestors to modern-day Basques, in contrast previous hypotheses that linked Basques to earlier pre-farming groups. The team could also demonstrate that farming was brought to Iberia by the same/similar groups that migrated to northern and central Europe and that the incoming farmers admixed with local, Iberian hunter-gather groups, a process that continued ...

'Clever adaptation' allows yeast infection fungus to evade immune system attack

2015-09-07
Johns Hopkins Bloomberg School of Public Health researchers say they have discovered a new way that the most prevalent disease-causing fungus can thwart immune system attacks. The findings, published Sept. 7 in the Proceedings of the National Academy of Sciences, offer new clues about how Candida albicans, the fungus responsible for vaginal yeast infections and the mouth infection thrush, is able to cause a deadly infection once it enters the bloodstream. When the body is faced with an infection, cells give a burst of free radicals to kill the germs. C. albicans ...

Mobile phone records may predict epidemics of mosquito-borne dengue virus

2015-09-07
Boston, MA -- A new study led by researchers at Harvard T.H. Chan School of Public Health finds that mobile phone records can be used to predict the geographical spread and timing of dengue epidemics. More people around the world are becoming vulnerable to this deadly virus as climate change expands the range of the mosquito that transmits dengue and infected travelers spread the disease across borders. Utilizing the largest data set of mobile phone records ever analyzed to estimate human mobility, the researchers developed an innovative model that can predict epidemics ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Secukinumab in plaque psoriasis: Manufacturer dossier provided no hint of an added benefit
Partly lack of suitable data, partly no relevant differences between the treatment groups